Terns Pharmaceuticals Inc (TERN) Insider Trading
- $40,130,701.65
- $11,211,305.27
- Dec. 5, 2024
- Vivo Opportunity, Llc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 5, 2024 | CEO | 15,450 | $7.15 | Buy | $110,467.50 | |
| Sept. 12, 2024 | Director | 476,190 | $10.50 | Buy | $4,999,995.00 | |
| Sept. 10, 2024 | CFO | 10,000 | $11.00 | Sell | $110,000.00 | |
| Sept. 9, 2024 | Director | 17,235 | $10.00 | Sell | $172,350.00 | |
| Aug. 1, 2024 | Director | 6,143 | $7.68 | Sell | $47,178.24 | |
| July 15, 2024 | Director | 50,976 | $10.00 | Sell | $509,760.00 | |
| April 3, 2024 | Major Shareholder | 138,066 | $6.20 | Sell | $856,009.20 | |
| April 1, 2024 | Major Shareholder | 181,117 | $6.99 | Sell | $1,266,007.83 | |
| Dec. 23, 2022 | Director | 137,931 | $7.25 | Buy | $999,999.75 | |
| Dec. 23, 2022 | Major Shareholder | 758,620 | $7.25 | Buy | $5,499,995.00 | |
| Nov. 23, 2022 | Major Shareholder | 1,500,000 | $5.50 | Sell | $8,250,000.00 | |
| Sept. 7, 2022 | Major Shareholder | 600,000 | $3.60 | Buy | $2,160,000.00 | |
| Aug. 16, 2022 | Director | 1,500,000 | $2.42 | Buy | $3,630,000.00 | |
| Aug. 15, 2022 | Major Shareholder | 1,218 | $2.99 | Buy | $3,641.82 | |
| Aug. 12, 2022 | Major Shareholder | 1,123,021 | $2.98 | Buy | $3,346,602.58 | |
| Feb. 9, 2021 | Insider | 665,000 | $17.00 | Buy | $11,305,000.00 | |
| Feb. 9, 2021 | Major Shareholder | 475,000 | $17.00 | Buy | $8,075,000.00 |
Insiders are both buying and selling Terns Pharmaceuticals Inc stock.
The insider traders at Terns Pharmaceuticals Inc are: Vivo Opportunity, Llc, Jill M Quigley, Hongbo Lu, Biosciences Fund V L.P. Lav, James E Flynn, Amy L Burroughs, Mark J Vignola, Orbimed Advisors Llc, Vivo Capital Fund Viii, L.P., and Carl L Gordon
The most active insider trader at Terns Pharmaceuticals Inc is Vivo Opportunity, Llc with 6 trades.
Biosciences Fund V L.P. Lav has sold the most Terns Pharmaceuticals Inc stock with a total value of $16,500,000.00.
James E Flynn has bought the most Terns Pharmaceuticals Inc stock with a total value of $22,610,000.00.
The most recent insider trade for Terns Pharmaceuticals Inc was on Dec. 5, 2024.
The single biggest insider buy for Terns Pharmaceuticals Inc was from James E Flynn with a total value of $11,305,000.00 on Feb. 9, 2021.
The single biggest insider sell for Terns Pharmaceuticals Inc was from Biosciences Fund V L.P. Lav with a total value of $8,250,000.00 on Nov. 23, 2022.